EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Transcriptomic Profiling of Cutaneous Melanoma Metastases Treated With Microwave Ablation—Pilot Study

Purevsuren Losol iD, Daniel O'Driscoll iD, Andres Vallejo Pulido iD, Adrian von Witzleben iD, Konstantinos Boukas iD, Matthew Sommerlad, Christian Ottensmeier iD, Michael R Ardern-Jones iD

Clinical and Translational Science · 2026-06 · 19 (6)

DOI: 10.1111/cts.70638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Science, online erschienen am 18.06.2026. Verfasst von Purevsuren Losol und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK. Hauptthemen laut MEDLINE: Melanoma, Microwaves, Skin Neoplasms. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK Centre Network Accelerator, the NIHR Southampton Clinical Research Facility, and generous donation from The Leon Crouch Foundation. Swift device was provided by Emblation Ltd..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Microwave ablation induces heating of tissue. High energy results in thermal cell death, but low energy treatment without tissue necrosis has been shown to induce cutaneous immunity in an HPV wart model. It is approved as an effective cancer treatment for solid organ cancers, and therefore it is of interest to know if microwave delivered directly to the skin holds potential for treatment of skin cancer. This pilot study focused on transcriptomic profiling of cutaneous melanoma metastases to investigate molecular changes associated with microwave therapy. Seven adult patients with skin metastases from malignant cutaneous melanoma, not resolving on standard treatment, were recruited. Microwave energy was applied to separate melanoma metastases. Morphological, histological, and transcriptomic changes assessed via tissue RNA sequencing were evaluated. Three participants showed complete response, while four showed partial response by histological assessment. In complete responders, skin lesion RNA sequencing after treatment, compared with baseline, identified increased inflammation ( CXCL5, CXCL8 , IL1A , COL1A1 ) and downregulated cancer markers ( PRAME , S100B , MLANA , STK32A ). Compared with partial responders, complete responders showed enrichment of FABP4 and reduced expression of cancer markers. Microwave therapy produced local tumor responses and associated inflammatory transcriptomic changes in complete responders, supporting further clinical evaluation in cutaneous melanoma metastases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaMicrowavesSkin NeoplasmsHumansPilot ProjectsMaleFemaleMiddle AgedGene Expression ProfilingAgedBiomarkers, TumorTreatment OutcomeTranscriptomeSkinAdultCutaneous Malignant MelanomaGene Expression Regulation, Neoplastic

Stichwörter der Autor:innen

melanomamicrowavetranscriptomicstreatment

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Department of Dermatology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Department of Dermatology, Imperial College Healthcare NHS Trust, London, UK.
  • Department of Otorhinolaryngology, Head and Neck Surgery, University of Ulm, Ulm, Germany.
  • Wessex Investigational Sciences Hub, Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.
  • Department of Histopathology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.

ORCID-Profile: Purevsuren Losol, Daniel O'Driscoll, Andres Vallejo Pulido, Adrian von Witzleben, Konstantinos Boukas, Christian Ottensmeier, Michael R Ardern-Jones

Förderung

  • Cancer Research UK Centre Network Accelerator
  • the NIHR Southampton Clinical Research Facility, and generous donation from The Leon Crouch Foundation. Swift device was provided by Emblation Ltd.

Zitieren

APA

Losol, P., O'Driscoll, D., Pulido, A. V., von Witzleben, A., Boukas, K., Sommerlad, M., Ottensmeier, C., & Ardern-Jones, M. R. (2026). Transcriptomic Profiling of Cutaneous Melanoma Metastases Treated With Microwave Ablation—Pilot Study. Clinical and Translational Science, 19(6). https://doi.org/10.1111/cts.70638

Vancouver

Losol P, O'Driscoll D, Pulido AV, von Witzleben A, Boukas K, Sommerlad M, et al. Transcriptomic Profiling of Cutaneous Melanoma Metastases Treated With Microwave Ablation—Pilot Study. Clinical and Translational Science. 2026;19(6). doi:10.1111/cts.70638

BibTeX
@article{Losol2026,
  author = {Losol, Purevsuren and O'Driscoll, Daniel and Pulido, Andres Vallejo and von Witzleben, Adrian and Boukas, Konstantinos and Sommerlad, Matthew and Ottensmeier, Christian and Ardern-Jones, Michael R},
  title = {Transcriptomic Profiling of Cutaneous Melanoma Metastases Treated With Microwave Ablation—Pilot Study},
  journal = {Clinical and Translational Science},
  year = {2026},
  volume = {19},
  number = {6},
  doi = {10.1111/cts.70638}
}
Kostenlos starten →